Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma

被引:41
作者
Cui, Wenli [1 ,2 ,3 ,4 ]
Cai, Ying [1 ,2 ,3 ]
Wang, Weige [1 ,2 ,3 ]
Liu, Zebing [1 ,2 ,3 ]
Wei, Ping [1 ,2 ,3 ]
Bi, Rui [1 ,2 ,3 ]
Chen, Weixiang [1 ,2 ,3 ]
Sun, Menghong [1 ,2 ,3 ]
Zhou, Xiaoyan [1 ,2 ,3 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Pathol, Shanghai 200032, Peoples R China
[4] Xinjiang Med Univ, Affiliated Hosp 1, Dept Pathol, Urumqi 830054, Xinjiang Uygur, Peoples R China
关键词
DLBCL; CNV; PI3K/AKT; Subunits; Survival; INTEGRATIVE GENOMIC ANALYSIS; GENE-EXPRESSION; AKT; PIK3CA; GROWTH; ISOFORMS; ROLES;
D O I
10.1186/1479-5876-12-10
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: It has been reported that the PI3K/AKT signaling pathway is activated in diffuse large B-cell lymphoma (DLBCL), PI3K constitutive activation plays a crucial role in PI3K/AKT pathway. However, the copy number variations (CNVs) of PI3K subunits on gene level remain unknown in DLBCL. Therefore, the aim of the study is to investigate the CNV of PI3K subunits and their relationship with clinicopathological features exploring the possible mechanism underlying of PI3K activation in DLBCL. Methods: CNV of 12 genes in the PI3K/AKT pathway was detected by NanoString nCounter in 60 de novo DLBCLs and 10 reactive hyperplasia specimens as controls. Meanwhile, immunohistochemistry (IHC) was performed to examine the expression of p110 alpha, p110 beta, p110 gamma, p110 delta, and pAKT on DLBCL tissue microarrays. Results: All PI3K and AKT subunits, except for PIK3R1, had various CNVs in the form of copy number amplifications and copy number losses. Their rates were in the range of 8.3-20.0%. Of them PIK3CA and PIK3CB gene CNVs were significantly associated with decreased overall survival (P = 0.029 and P = 0.019, respectively). IHC showed that the frequency of strong positive expression of p110 alpha, p110 beta, p110 gamma, and p110 delta were 26.7%, 25.0%, 18.3%, and 25.0% respectively, and they were found to be associated with decreased survival (P = 0.022, P = 0.015, P = 0.015, and P = 0.008, respectively). Expression of p110 alpha was not only significantly associated with CNVs of PIK3CA (P = 0.002) but also positively correlated with strong positive expression of pAKT (P = 0.026). Conclusions: CNV of PIK3CA is highly associated with aberrant p110a protein expression and subsequent activation of PI3K/AKT pathway. CNVs of PIK3CA and PIK3CB, and aberrant protein expression of p110 isoforms are of great important value for predicting inferior prognosis in DLBCL. Frequent CNVs of PI3K/AKT subunits may play an important role in the tumorigenesis of DLBCL.
引用
收藏
页数:11
相关论文
共 27 条
[1]   PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events [J].
Agell, Laia ;
Hernandez, Silvia ;
Salido, Marta ;
de Muga, Silvia ;
Juanpere, Nuria ;
Arumi-Uria, Montserrat ;
Menendez, Silvia ;
Lorenzo, Marta ;
Lorente, Jose A. ;
Serrano, Sergio ;
Lloreta, Josep .
MODERN PATHOLOGY, 2011, 24 (03) :443-452
[2]   Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer [J].
Aleskandarany, Mohammed A. ;
Rakha, Emad A. ;
Ahmed, Mohamed A. ;
Powe, Desmond G. ;
Ellis, Ian O. ;
Green, Andrew R. .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) :407-416
[3]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[4]  
Baohua Yu, 2008, Diagn Mol Pathol, V17, P159, DOI 10.1097/PDM.0b013e31815d0588
[5]   The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation [J].
Beer-Hammer, Sandra ;
Zebedin, Eva ;
von Holleben, Max ;
Alferink, Judith ;
Reis, Bernhard ;
Dresing, Philipp ;
Degrandi, Daniel ;
Scheu, Stefanie ;
Hirsch, Emilio ;
Sexl, Veronika ;
Pfeffer, Klaus ;
Nuernberg, Bernd ;
Piekorz, Roland P. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (06) :1083-1095
[6]   Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia [J].
Brown, Jennifer R. ;
Hanna, Megan ;
Tesar, Bethany ;
Werner, Lillian ;
Pochet, Nathalie ;
Asara, John M. ;
Wang, Yaoyu E. ;
dal Cin, Paola ;
Fernandes, Stacey M. ;
Thompson, Christina ;
MacConaill, Laura ;
Wu, Catherine J. ;
Van de Peer, Yves ;
Correll, Mick ;
Regev, Aviv ;
Neuberg, Donna ;
Freedman, Arnold S. .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3791-3802
[7]   The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism [J].
Engelman, Jeffrey A. ;
Luo, Ji ;
Cantley, Lewis C. .
NATURE REVIEWS GENETICS, 2006, 7 (08) :606-619
[8]   Direct multiplexed measurement of gene expression with color-coded probe pairs [J].
Geiss, Gary K. ;
Bumgarner, Roger E. ;
Birditt, Brian ;
Dahl, Timothy ;
Dowidar, Naeem ;
Dunaway, Dwayne L. ;
Fell, H. Perry ;
Ferree, Sean ;
George, Renee D. ;
Grogan, Tammy ;
James, Jeffrey J. ;
Maysuria, Malini ;
Mitton, Jeffrey D. ;
Oliveri, Paola ;
Osborn, Jennifer L. ;
Peng, Tao ;
Ratcliffe, Amber L. ;
Webster, Philippa J. ;
Davidson, Eric H. ;
Hood, Leroy .
NATURE BIOTECHNOLOGY, 2008, 26 (03) :317-325
[9]   Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells [J].
Grabinski, Nicole ;
Bartkowiak, Kai ;
Grupp, Katharina ;
Brandt, Burkhard ;
Pantel, Klaus ;
Juecker, Manfred .
CELLULAR SIGNALLING, 2011, 23 (12) :1952-1960
[10]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282